🇺🇸 FDA
Pipeline program

MIE

201412

Phase 3 other active

Quick answer

MIE for Esophageal Carcinoma is a Phase 3 program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Esophageal Carcinoma
Phase
Phase 3
Modality
other
Status
active

Clinical trials